You are here > Volunteers > Current Trials


To get notified of upcoming trials via Facebook visit our Q-Pharm Facebook page and 'like us'!

HAVE YOU BEEN RECEIVING OUR TRIAL NOTIFICATION EMAILS? If you are registered on our volunteer database to receive trial notifications via email, please add the following email address to your safe senders list to ensure that you receive the notifications:

For further information on any of the trials listed below please contact Q-Pharm Recruitment on 1300 QPHARM (1300 774 276 voicemail) or email us at

Please note all trials are conducted at our clinic located in the Clive Berghofer Cancer Research Centre, Level 5, 300c Herston Road HERSTON QLD 4006.

General Advertisment for Participants
Study code Study overview Eligibility Criteria Required Visit schedule summary Approximate visit dates

Further Information
Volunteers required to participate in clinical trials of new drugs and vaccines. - Healthy Females and Males.
- Aged between 18 to 85 years.
- BMI between 18 and 32.


- Screening medical.
- In addition some trials may require a number of clinic visit for 1 – 2 hour periods and or in-house stays at Q-Pharm clinic from 12 hours or as long as 7 days. 
 -Trial dependent.

Please register via the 'Volunteer Registration' section under the 'Volunteers' tab.


Healthy Participants
Study code Study overview Eligibility Criteria Required Visit schedule summary Approximate visit dates
QP14C14 Flu Vaccine

- Males and Females 65 to 75 years of age

- No history of cancer within the last 3 years excluding minor skin cancers.

- Must not have had any licensed or investigational influenza vaccine within 6 months prior to commencement of the trial.

- Able to attend a medical screening visit.

- Vaccination visit and 3 follow up visits to the clinic all within a 21 day period.

- 2 phone calls, day 180 and day 360.

- Length of trial 12 months.

Commencement dates from March, 2015.

Further dates will be available, yet to be advised.

QP14C20 Ebola Vaccine

- Males only 18 to 49 years of age

- No serious reactions to previous vaccinations.

- No known or suspected immunosuppressive conditions

- No vaccine within 4 weeks prior to first vaccination for Ebola.

- No vaccine until Day 84 is completed.

- 8 x outpatient visits including the 2 vaccination visits.

The first vaccination visit includes medical screening.

- 1 x phone call.

Commencement Dates:

Mon 2nd March, 2015

Tues 3rd March, 2015

Wed 4th March, 2015

QP14C07 Male Pattern Baldness

- Males only 18 to 60 years of age

- Not have used any scalp hair growth products within 12 weeks of commencement  of trial

- Must now have had a clinical diagnosis of alopecia areata

- Must not have a current skin disease

- Must now have had use of finasteride, dutasteride, minoxidil within 12 weeks of commencement of trial


- Able to attend a medical screening visit

- 15 consecutive visits to the clinic, 2 of these visits will last approx. 12 hours

- 1 final visit

Trial is now closed to further recruitment.

Further trial available, dates still to be confirmed.


New Treatment For Respiratory Tract Infections


- Males and Females

- 18 - 55 years of age inclusive

- Females must be post menopausal or surgically sterile.

-Non Smoker

- Able to attend 1 x 9 night confinement

- 2 x Follow up visits (approx. 1 hour each)

Recruiting Now

Commencement Date:

Monday 23rd March, 2015, start of 9 day confinement period.

QP13C02 New treatment for malaria

- Healthy and between the ages of 18 to 55 years.

- Males or Post Menopausal Women

- Practicing effective contraception.

- Currently on no medications

- Willing to cease smoking and limit alcohol consumption.

Able to attend a 3 night stay and 5 follow up visits. 

Cohort 8A now closed.


A possible further cohort will be running.

Dates still to be advised.

QP14C09 Research for new muscle relaxant
- Healthy Males between the ages 18 - 50 years.
- Practicing effective contraception with their partners.
- Currently on no medications.
- If a smoker must smoke < 5 a day and able to abstain from screening until end of confinement.
- Cannot participate in activity/sport which requires high load and intensity to the foot whilst on the study.
Able to attend 2 medicals, 1 pre-dose visit, 1 x 48 hour confinement period and 5 follow up outpatient visits over a 3 month period.

Cohort 3 Recruiting Now.

Commencement dates:

Choose either Monday 23rd March or Monday 13th April, 2015. 


QP14C17 Overweight Type 2 Diabetics

- Males and Females

-Aged 18 - 65 years

- BMI 30 - 60

- Type 2 diabetic controlled with diet and exercise along and/or with stable treatment.

- A medical screening visit.

- At least 12 outpatient visits over a year.

Recruiting Now.

Various dosing dates available.

Next date 16th March, 2015.

QP14C12 New treatment for Malaria

- Males Only aged 18-55 years.

- Generally healthy

-Must not have travelled or lived > 2 weeks in a malaria endemic country last 12 months.

- Must not have a history of malaria or completed a previous malaria trial.

- Social smokers must be willing to cease smoking for the duration of the trial.

- Must not be on prescription medications 4 weeks prior to commencement of the trial or over the counter supplements 14 days prior to the commencement of the trial.


Able to attend a 2 night confinement and a 5 hour confinement.

- Approximately 20 follow up visits.

- Some AM/PM visits

Cohort 1 now closed to further recruitment.


Cohort 2 dates yet to be confirmed.

QP13C05 New treatment for Malaria.

- Males and Females

- Generally healthy.

- Aged 18-45 inclusive.

- Practicing effective contraception.

- Non Smokers.

- Must not have travelled to or lived (>2 weeks) in a malaria endemic country in the past 12 months.

- Must not have had malaria previously.

- Must not be taking any prescription medications or over-the-counter supplements for 2 weeks prior to commencement of the trial.


Please contact Q-Pharm for full information on eligibility criteria. 


Able to attend a 2 night stay and a 12 hour confinement period.

-32 Outpatient visits approx.

-3 Follow Up Phone Calls

Cohort 3B now closed.


 A further cohort yet to be confirmed.


Patient Based Participants
Study code Study overview Eligibility Criteria Required Visit schedule summary Approximate visit dates
QP14C16 HSV-2 Vaccine

- Males and Females

- 18 - 50 years old

- HSV-2 Positive

- No anti viral medications

- No Cancer treatment




- 13 month trial period

- Able to attend a medical Screening Visit

- 3 x Vaccination Visits plus a booster vaccination at 6 month

- 12 x outpatient visits

- 5 x phone calls


- To commence March 2015.


All studies at Q-Pharm are conducted under Australian and International guidelines for medical research under the approval of a Human Research Ethics Committee that complies with the strict guidelines as set by the National Health and Medical Research Council. Participation in a trial is dependent on fulfilment of trial specific criteria and overseas visitors require appropriate visas for trial participation.